You are using an outdated browser. Please upgrade your browser to improve your experience.

larotrectinib

Ligand Summary
Ligand Structure
Rendered image for the query structure
Description
Larotrectinib is an inhibitor of the tropomyosin receptor kinases (TRK), TRKA, TRKB, and TRKC. In a broad panel of purified enzyme assays, larotrectinib inhibited TRKA, TRKB, and TRKC with IC50 values between 5-11 nM. One other kinase TNK2 was inhibited at approximately 100-fold higher concentration. TRKA, B, and C are encoded by the genes NTRK1, NTRK2, and NTRK3.Chromosomal rearrangements involving in-frame fusions of these genes with various partners can result in constitutively-activated chimeric TRK fusion proteins that can act as an oncogenic driver, promoting cell proliferation and survival in tumor cell lines.
Synonyms & Links
Guide to Pharmacology: 8909
DrugCentral: 5305
LyCHI:  C82NSTPT86PG


Target Activities